|
|
 |
|
Viewing report
|
|
|
|
Nrt Smoking Cessation Aids in USA
Euromonitor International, March 2010, Pages: 51
Value sales of smoking cessation products inched up slightly in 2009, after two years of declines. The stagnant performance of the OTC smoking cessation treatments was not for want of US consumers looking to quit smoking, but rather the emergence of cheaper private label products and the brief rise of Chantix, an Rx cessation treatment. Private label performance in the NRT sector was perhaps the strongest of all other consumer health sectors. The category only has one branded manufacturer which...
The NRT Smoking Cessation Aids Products in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Consumer Health industry;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
.
Customers who bought this item also bought
NRT Smoking Cessation Aids in Philippines
NRT Smoking Cessation Aids in United Arab Emirates
NRT Smoking Cessation Aids in France
NRT Smoking Cessation Aids in South Africa
NRT Smoking Cessation Aids in Mexico
Nrt Smoking Cessation Aids in Singapore
NRT Smoking Cessation Aids in India
NRT Smoking Cessation Aids in the US
NRT Smoking Cessation Aids in the United Kingdom
NRT Smoking Cessation Aids in Algeria
|
|
|
|
